Albuminuria changes are associated with subsequent risk of end-stage renal disease and mortality-Reference-Cited by-同舟云学术

Albuminuria changes are associated with subsequent risk of end-stage renal disease and mortality

Published:2017-01 Issue:1 Volume:91 Page:244-251
ISSN:0085-2538
Container-title:Kidney International
language:en
Short-container-title:Kidney International

Author:

Carrero Juan Jesús,Grams Morgan E.,Sang Yingying,Ärnlöv Johan,Gasparini Alessandro,Matsushita Kunihiro,Qureshi Abdul R.,Evans Marie,Barany Peter,Lindholm Bengt,Ballew Shoshana H.,Levey Andrew S.,Gansevoort Ron T.,Elinder Carl G.,Coresh Josef

Publisher

Elsevier BV

Subject

Nephrology

Reference30 articles.

1. Evolving importance of kidney disease: from subspecialty to global health burden;Eckardt;Lancet,2013

2. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification;National Kidney Foundation;Am J Kidney Dis,2002

3. Evaluation and management of chronic kidney disease: synopsis of the kidney disease: improving global outcomes 2012 clinical practice guideline;Stevens;Ann Intern Med,2013

4. KDIGO clinical practice guideline for the evaluation and management of chronic kidney disease;Kidney Int Suppl,2013

5. Screening, monitoring, and treatment of stage 1 to 3 chronic kidney disease: a clinical practice guideline from the American College of Physicians;Qaseem;Ann Intern Med,2013

Cited by 113 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Finerenone: A Novel Drug Discovery for the Treatment of Chronic Kidney Disease;Current Drug Discovery Technologies;2024-11

2. Risk Factors for Renal Function Progression in Patients with CKD Complicated by COPD;2024-08-09

3. Biomarkers of chronic kidney disease in older individuals: navigating complexity in diagnosis;Frontiers in Medicine;2024-07-11

4. Individualized Risk of CKD Progression among US Adults;Journal of the American Society of Nephrology;2024-05-15

5. Mineralocorticoid receptor antagonists and reno‐protection: What's the evidence & where do they fit? A guide for non‐specialists;Diabetes, Obesity and Metabolism;2024-05-07